News Headlines Article

House passes FDA user-fee legislation
Modern Healthcare

The House of Representatives passed by voice vote a bipartisan bill to reauthorize Food and Drug Administration user fees for another five years and to create a new generic drug user-fee program.

The bill is a negotiated compromise (PDF) between similar measures that separately passed the House and Senate last month. The Senate is expected to vote on the compromise measure—one of the few major pieces of legislation to advance in both chambers this year—as soon as Thursday.